Ascent Scientific launches low-cost Kainic Acid – a vital research tool for neuroscientists

Ascent Scientific (www.ascentscientific.com) announced the addition of Kainic acid to the Low-Cost Ligand™ range. This standard tool is widely used by scientists – helping research into a vast range of medical conditions including pain, epilepsy, cognitive and neurodegenerative disorders.

Kainic acid is isolated from certain species of seaweed, and acts on a group of protein structures in the brain, that are known as the ionotropic glutamate receptors. Other ionotropic glutamate receptor tools in the Low-Cost Ligand™ range include D-AP5, NBQX and MK801.

Steve Roome PhD, Commercial Director commented, “Kainic acid is used by researchers worldwide, but up until now, many laboratories have struggled to purchase it and limited their research, due to the high price demanded by other suppliers. In addition, availability has been erratic. We are pleased to be able to offer an alternative supply of this vital research tool at a price up to 50% less than other suppliers – with the Ascent Scientific pledge to exceptional quality.”


Contact: Steve Roome, Commercial Director +44 (0)1934 624 695 steveroome@ascentscientific.co.uk

About Ascent Scientific
Ascent Scientific provides high quality receptor ligands, synthetic chemistry, research, consultancy and analytical services for life science, pharmaceutical and chemistry-related industries.

The Low-Cost Ligand™ range includes:
AMN082: the first selective mGlu7 agonist

- L-AP4: selective group III mGlu agonist
- D-AP5: Potent selective NMDA antagonist
- Capsazepine: VR1 antagonist
- Fenobam: mGlu5 antagonist
- (+)-MK-801: non competitive NMDA antagonist
- MPEP: mGlu5 selective antagonist
- YM-298198:potent, selective mGlu1 antagonist